Your browser doesn't support javascript.
loading
Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?
Qin, Kirby R; Mertens, Eveline; Tempo, Jake A; Perera, Marlon; Brennan, Janelle.
Affiliation
  • Qin KR; Department of Urology, Bendigo Health, Bendigo, VIC, Australia.
  • Mertens E; School of Rural Health, Monash University, Bendigo, VIC, Australia.
  • Tempo JA; Department of Paediatrics, Monash University, Melbourne, VIC, Australia.
  • Perera M; Department of Urology, Bendigo Health, Bendigo, VIC, Australia.
  • Brennan J; Department of Urology, Austin Health, Melbourne, VIC, Australia.
Transl Androl Urol ; 13(5): 920-922, 2024 May 31.
Article in En | MEDLINE | ID: mdl-38855582
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Androl Urol Year: 2024 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Androl Urol Year: 2024 Type: Article Affiliation country: Australia